glutathione treatment for parkinson& 39 Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions Glutathione S-transferase: A keystone in
Description
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway
doi: 10.1016/j.jgg.2024.01.006 199 ZhangJ.-B.HeS.-P.LuoJ.-W.WangX.-P.LiD.-D.LiX.-B
The new drug targets a group of proteins in the body known as ERRs, which are responsible for activating some of the most important metabolic pathways in energy-gobbling tissues like muscles, the heart, and the brain
Neuroscience and Behavioral Physiology, 22 (4), 275-279
